Reporter construct of TR response element
Alternative name | 2485C3F |
---|---|
Clone info. | Thyroid hormone response element (TRE-DR4) is cloned into the BglII site of phRL-TK, and the BglII site is killed by the cloning. The nucleotide sequence of the TRE is 5'-gatccaggtcaaaaaaggtcag-3'. (Ref: Endocrinol. 135: 1628-1638, 1994) |
Comment | The nucleotide sequence of the element was determined. Function of the inserted element has not been examined by the depositor. |
Vector backbone | phRL-TK (Plasmid) |
Size of vector backbone | 4.0 kb |
Selectable markers | Amp^r |
Gene/insert name | Artificial TR response element synthesized |
Depositor|Developer | Yokoyama, Kazunari | |
Remarks, protocol and/or map (pdf) | RDB05630.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to expressly describe the acknowledgement of the Gene Engineering Division, RIKEN BRC as the source of the BIOLOGICAL RESOURCE in any publication. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit organization for a not-for-profit research. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | リソースを使用して論文を投稿する場合、理研BRC・遺伝子材料開発室から分譲された事を記載する。本件リソースは非営利機関にのみ提供し、非営利研究にのみ利用することができる。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05630 | pTR RE-TK hRluc(F) | DNA solution |
Materials & Methods section:
The pTR RE-TK hRluc(F) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05630). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB16935_A9C4p1-1.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: SV40pA3'ElementReverse () Sequence file: RDB16935_A9C4a.seq |
---|
>05630_16935_A9C4_3_SV40pA3'ElementReverse_A02_01_ABI08.ab1 1 GGTCGGTTTG GGGGGGGCGG AGCCTATGGA AAACGCCAGC AACGCGGCCT TTTTACGGTT 61 CCTGGCCTTT TGCTGGCCTT TTGCTCACAT GGCTCGACAG ATCCAGGTCA AAAAAGGTCA 121 GGATCTAAAT GAGTCTTCGG ACCTCGCGGG GGCCGCTTAA GCGGTGGTTA GGGTTTGTCT 181 GACGCGGGGG GAGGGGGAAG GAACGAAACA CTCTCATTCG GAGGCGGCTC GGGGTTTGGT 241 CTTGGTGGCC ACGGGCACGC AGAAGAGCGC CGCGATCCTC TTAAGCACCC CCCCGCCCTC 301 CGTGGAGGCG GGGGTTTGGT CGGCGGGTGG TAACTGGCGG GCCGCTGACT CGGGCGGGTC 361 GCGCGCCCCA GAGTGTGACC TTTTCGGTCT GCTCGCAGAC CCCCGGGCGG CGCCGCCGCG 421 GCGGCGACGG GCTCGCTGGG TCCTAGGCTC CATGGGGACC GTATACGTGG ACAGGCTCTG 481 GAGCATCCGC ACGACTGCGG TGATATTACC GGAGACCTTC TGCGGGACGA GCCGGGTCAC 541 GCGGCTGACG CGGAGCGTCC GTTGGGCGAC AAACACCAGG ACGGGGCACA GGTACACTAT 601 CTTGTCACCC GGAGGCGCGA GGGACTGCAG GAGCTTCAGG GAGTGGCGCA GCTGCTTCAT 661 CCCCGTGGCC CGTTGCTCGC GTTTGCTGGC GGTGTCCCCG GAAGAAATAT ATTTGCATGT 721 CTTTAGTTCT ATGATGACTC CAACCCCGCC CAGCGTCCTT GT // |
Primer: Tkpro-F () Sequence file: RDB16935_A9C4b.seq |
>05630_16935_A9C4_3_Tkpro-F_B02_02_ABI08.ab1 1 CGGGGTGCCT CGAACCCGAG CGACCCTGCA GCGACCCGCT TAAAAGCTTG ATTCTTCTGA 61 CACAACAGTC TCGAACTTAA GCTGCAGAAG TTGGTCGTGA GGCACTGGGC AGGTAAGTAT 121 CAAGGTTACA AGACAGGTTT AAGGAGACCA ATAGAAACTG GGCTTGTCGA GACAGAGAAG 181 ACTCTTGCGT TTCTGATAGG CACCTATTGG TCTTACTGAC ATCCACTTTG CCTTTCTCTC 241 CACAGGTGTC CACTCCCAGT TCAATTACAG CTCTTAAGGC TAGAGTACTT AATACGACTC 301 ACTATAGGCT AGCCACCATG GCTTCCAAGG TGTACGACCC CGAGCAACGC AAACGCATGA 361 TCACTGGGCC TCAGTGGTGG GCTCGCTGCA AGCAAATGAA CGTGCTGGAC TCCTTCATCA 421 ACTACTATGA TTCCGAGAAG CACGCCGAGA ACGCCGTGAT TTTTCTGCAT GGTAACGCTG 481 CCTCCAGCTA CCTGTGGAGG CACGTCGTGC CTCACATCGA GCCCGTGGCT AGATGCATCA 541 TCCCTGATCT GATCGGAATG GGTAAGTCCG GCAAGAGCGG GAATGGCTCA TATCGCCTCC 601 TGGATCACTA CAAGTACCTC ACCGCTTGGT TCGAGCTGCT GAACCTTCCA AAGAAAATCA 661 TCTTTGTGGG CCACGACTGG GGGGCTTGTC TGGCCTTTCA CTACTCCTAC GAGCACCAAG 721 ACAAGATCAA GGCCATCGTC CATGCTGAGA GTGTCGTGGA CGTGATCGAG TCCTGGGACG 781 AGTGGCCTGA CATCGAGGAG GATATCGCCC TGATCAAGAG CGAAAGAGGG CGAGAAAATG 841 GTGCTTGAGA ATAACTTTCT TCGTCGAGAC CATGCTCCCA AGCAAGATCA TGCGGAAACT 901 GGGAGCCTGA GGAGTTCGCT GCCTACCTGG AGGCCATTCA AGGAGAAGGG CGAGGTTAGA 961 CGGCCTACCC TCTCCTGGCC TCGCTAGATC CCCTCTCGTT AAGGGAGGAA GCCCGACGTC 1021 GTCCAAATTG TCCGCAACTA CAACGCCTAC CCTTCCGGGC CCGCGACCAA TCTGGCTT // |
Primer: pGCAP_R () Sequence file: RDB16935_A9C4c.seq |
>05630_16935_A9C4_3_pGCAP_R_C02_03_ABI08.ab1 1 CGGGAAACTT ATCATGTCTG CTCGAAGCGG CCGCTCTAGA ATTACTGCTC GTTCTTCAGC 61 ACGCGCTCCA CGAAGCTCTT GATGTACTTA CCCATTTCAT CTGGAGCGTC CTCCTGGCTG 121 AAGTGGAGGC CCTTCACCTT CACGAACTCG GTGTTAGGGA ACTTCTTAGC TCCCTCGACA 181 ATAGCGTTGG AAAAGAACCC AGGGTCGGAC TCGATGAACA TCTTAGGCAG ATCGTCGCTG 241 GCCCGAAGGT AGGCGTTGTA GTTGCGGACA ATCTGGACGA CGTCGGGCTT GCCTCCCTTA 301 ACGAGAGGGA TCTCGCGAGG CCAGGAGAGG GTAGGCCGTC TAACCTCGCC CTTCTCCTTG 361 AATGGCTCCA GGTAGGCAGC GAACTCCTCA GGCTCCAGTT TCCGCATGAT CTTGCTTGGG 421 AGCATGGTCT CGACGAAGAA GTTATTCTCA AGCACCATTT TCTCGCCCTC TTCGCTCTTG 481 ATCAGGGCGA TATCCTCCTC GATGTCAGGC CACTCGTCCC AGGACTCGAT CACGTCCACG 541 ACACTCTCAG CATGGACGAT GGCCTTGATC TTGTCTTGGT GCTCGTAGGA GTAGTGAAAG 601 GCCAGACAAG CCCCCCAGTC GTGGCCCACA AAGATGATTT TCTTTGGAAG GTTCAGCAGC 661 TCGAACCAAG CGGTGAGGTA CTTGTAGTGA TCCAGGAGGC GATATGAGCC ATTCCCGCTC 721 TTGCCGGACT TACCCATTCC GATCAGATCA GGGATGATGC ATCTAGCCAC GGGCTCGATG 781 TGAGGCACGA CGTGCCTCCA CAGGTAGCTG GAGGCAGCGT TACCATGCAG AAAAATCACG 841 GCGTTCTCGG CGTGCTTCTC GGAATCATAG TAGTTGATGA AGGGAGTCCA GCACGTTCAT 901 TTGCTTGCAG CGAGCCCACC ACTGAGGCCC AAGTGATCAT GCGTTTGCGT TGCTCGGGGT 961 TCGTACACCT TGGAAAGCCA TGGTGGGCTA GCCCTATAGT GAAGTCGTAT TTAAGTACTC 1021 TTAGCCTTTA AGAGCTGGTA TTTGAACTGG GAAGTGGAAC ACCTGTTGAA GAGAAAGGCA 1081 AAGTGGGATG TCAGTAGAAC AAATAGGCTG CCTATTCAGA ACCGCAAGAA AGTCTGTGTC 1141 TGGTCCTCGA CCAGCCCAAT TCTATTTGGT CTTCCGTTAA CCTTGTCTGT GTAACTCTGG 1201 ATTACCCTAC CCTGTCCCGA TGGCGGCCGC TCT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content